Assessment of epidemiological and spatial factors associated with physical disabilities due to leprosy at the end of treatment
DOI:
https://doi.org/10.26694/repis.v11i1.6316Keywords:
Brazil, Geographic information system, Healthcare services, Leprosy, Physical disabilitiesAbstract
Introduction: Identifying clinical, epidemiological, and operational factors associated with the development of physical disabilities (PD) after leprosy treatment is essential to improve prevention and care strategies, reduce the socioeconomic impact of the disease, and improve the quality of life of those affected. Objective: Therefore, this study evaluated the factors associated with the presence of PD at the end of treatment in a hyperendemic setting. Method: This was a retrospective study of 495 leprosy patients living in Cáceres, Mato Grosso (MT), using data obtained from the Regional Health Office. Epidemiological, clinical, and geospatial variables were analyzed. Data analysis was performed using logistic regression, with a p-value <0.05 considered significant. An analysis of the spatial flow between the patients' place of residence and the health services responsible for reporting was also performed. Results: Among the 247 records with complete data, the independent factors associated with PD at the end of treatment were: age (odds ratio [OR], 1.04 [1.02–1.08]; p<0.01), multibacillary operational classification (OR, 2.69 [1.08–6.71]; p=0.03), and presence of PD at diagnosis (OR, 5.10 [2.07–12.55]; p<0.01). In the geospatial analysis, centralization of care was observed in a reference service, with a mean patient travel distance of 2.09 km. This service concentrated 76.5% of the notifications; the remaining 23.5% were notified by primary health care (PHC). Implications: The findings suggest late detection and highlight the need to strengthen PHC for early diagnosis and systematic monitoring of PD, starting at the time of diagnosis, in order to reduce PD rates at the end of treatment.
References
Britton WJ, Lockwood DNJ. Leprosy. Lancet. 2004;363(9416):1209-19. Available from: https://doi.org/110.1016/S0140-6736(04)15952-7
Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol. 2008;130(6):856-64. Available from: https://doi.org/10.1309/AJCPP72FJZZRRVMM
Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, et al. Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J Bacteriol. 2009;191(19):6067-74. Available from: https://doi.org/10.1128/JB.00762-09
Scollard DM. Editorial: Infection with Mycobacterium lepromatosis. Am J Trop Med Hyg. 2016;95(3):5001. Available from: https://doi.org/10.4269/ajtmh.16-0473
William RLM, Shali Zhang B, Martiniuk F. Mycobacterium lepromatosis: Emerging strein or species. J Drugs Dermatology. 2012;11(2):158. Available from: https://pubmed.ncbi.nlm.nih.gov/22402645/
Brandsma JW, Van Brakel WH. WHO disability grading: Operational definitions. Lepr Rev. 2003;74(4):366-73. Available from: https://pubmed.ncbi.nlm.nih.gov/14750582/
World Health Organization. Weekly epidemiological record. Wkly Epidemiol Rec [Internet]. 2020;95(36):417-40. Available from: http://www.who.int/wer
Blas E, Kurupo AS. Neglected tropical diseases: equity and social determinants and public health programmes. World Health Organization. Geneva; 2010. Available from: https://apps.who.int/iris/handle/10665/44289
World Health Organization. Towards zero leprosy - Global Leprosy (Hansen’s disease) Strategy 2021–2030 [Internet]. 2021. Available from: https://www.who.int/publications/i/item/9789290228509
Brasil. Ministry of Health. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Estratégia Nacional para Enfrentamento da Hanseníase 2019-2022. Brasília: Ministério da Saúde; 2020. Available from: http://www.aids.gov.br/pt-br/pub/2020/estrategia-nacional-para-enfrentamento-da-hanseniase-20192022
Brasil. Ministry of Health. Portaria No 1.996, 20 de Agosto de 2007. Brasília: Diário Oficial da União; 2007. Avaliable from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2007/prt1996_20_08_2007.html
Macinko J, Harris MJ. Brazil's family health strategy-delivering community-based primary care in a universal health system. N Engl J Med. 2015;372(23):2177-81. Avaliable from: https://doi.org/10.1056/NEJMp1501140
Control of Neglected Tropical Diseases (NTD. Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible – Time to act! [Internet]. World Health Organization; 2024 [cited 2025 Sep 18]. Available from: https://www.who.int/publications/i/item/who-wer9937-501-521
Brazil Ministry of Health. Secretaria de Vigilância em Saúde. Boletim Epidemiológico de Hanseníase. Brasília; 2024. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2024/be_hansen-2024_19jan_final.pdf
Sanchez MN, Nery JS, Pescarini JM, Mendes AA, Ichihara MY, Teixeira CSS, et al. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC Infect Dis. 2021;21(1):11-1. Available from: https://doi.org/10.1186/s12879-021-05846-w
Andrade KVF, Silva Nery J, Moreira Pescarini J, Ramond A, Souza Teles Santos CA, Ichihara MY, et al. Geographic and socioeconomic factors associated with leprosy treatment default: An analysis from the 100 Million Brazilian Cohort. PLoS Negl Trop Dis. 2019;13(9). Available from: https://doi.org/10.1371/journal.pntd.0007714
Sistema de Tabulação de Dados - TabNet Win. Acompanhamento dos dados de Hanseníase - Mato Grosso [Internet]. Datasus.gov.br. 2025 [cited 2025 Sep 19]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/hanswmt.def
Ministério da Saúde. Hanseníase no Brasil: caracterização das incapacidades físicas. Brasília: Ministério da Saúde, 2020. 96 p. [cited 2025 Sep 19]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/hanseniase_brasil_caracterizacao_incapacidades_fisicas.pdf
Brazilian Institute of Geography and Statistics. Download para fins estatísticos. 2020. Available from: https://www.ibge.gov.br/geociencias/downloads-geociencias.html
Rabino GA, Occelli S. Understanding spatial structure from network data: theoretical considerations and applications. OpenEd Journals; 1977. p. 21-1. Available from: http://journals.openedition.org/cybergeo/2199
Alencar CHM, Ramos AN, Neto SAS, Murto C, Alencar MJF, Barbosa JC, et al. Diagnóstico da hanseníase fora do município de residência: Uma abordagem espacial, 2001 a 2009. Cad Saude Publica. 2012;28(9):1685-98. Available from: https://doi.org/10.1590/S0102-311X2012000900008
Ferreira TC, Rigoli FH. Territórios e fluxos na conformação do sistema de saúde: a contribuição do geoprocessamento. In: Ribeiro H, editor. Geoprocessamento em saúde, muito além de mapas. São Paulo: Manole; 2017. p. 50-31.
Santos, Byrne RL, Cubas-Atienzar AI, Santos VS. Factors associated with delayed diagnosis of leprosy in an endemic area in Northeastern Brazil: a cross-sectional study. Cadernos de Saúde Pública [Internet]. 2024 Jan 1 [cited 2025 Sep 19];40(1). Doi: https://doi.org/10.1590/0102-311XEN113123
Raposo MT, Reis MC, Caminha AVdQ, Heukelbach J, Parker LA, et al. Grade 2 disabilities in leprosy patients from Brazil: Need for follow-up after completion of multidrug therapy. PLOS Neglected Tropical Diseases. 2021;12(7): e0006645. doi:10.1371/journal.pntd.0006645
Smith WC, Nicholls PG, Das L, Barkataki P, Suneetha S, Suneetha L, Jadhav R, Sundar Rao PS, Wilder-Smith EP, Lockwood DN, van Brakel WH. Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study. PLoS Negl Trop Dis. 2009;3(8):e500. doi: 10.1371/journal.pntd.0000500
Virmond M, Grzybowski A, Virmond L. Leprosy: a glossary. Clin Dermatol. 2015;33(1):8-18. doi:10.1016/j.clindermatol.2014.07.006 4
Van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DN. Early diagnosis of neuropathy in leprosy—comparing diagnostic tests in a large prospective study (the INFIR Cohort Study). PLoS Negl Trop Dis. 2012;6(5):e1813. doi:10.1371/journal.pntd.0001813
Monteiro LD, Alencar CH, Barbosa JC, Braga KP, Castro MD, Heukelbach J. Physical disabilities in leprosy patients after discharge from multidrug therapy in Northern Brazil. Cad Saude Publica. 2013;29(5):909-920. doi:10.1590/S0102-311X2013000500009
Oliveira NG. Parâmetros epidemiológicos, espaciais e qualitativos do perfil da Hanseníase em munícipio endêmico do Alto Pantanal/ MT. Universidade Estadual Paulista (Unesp). 2020. Available from: https://repositorio.unesp.br/entities/publication/f1ceb7e9-45f5-40bc-ad98-29af06a91a81
Lana, FC F, Lanza, FM, Carvalho, APM, Tavares, APN. O estigma em hanseníase e sua relação com as ações de controle. Rev Enfer da UFSM,2014;4(3),556–565. doi.org/10.5902/2179769212550
Lanza FM, Félix Lana FC. Decentralization of leprosy control actions in the micro-region of Almenara, State of Minas Gerais. Rev Lat Am Enfermagem. 2011;19(1):187-94. doi: 10.1590/s0104-11692011000100025.
Kalk A, Fleischer K. The decentralization of the health system in Colombia and Brazil and its impact on leprosy control. Lepr Rev. 2004 Mar;75(1):67-78.
MM da Silva, Oliveira ALS de, Schindler HC. Evaluation of completeness, consistency and non-duplication of leprosy notification data on the Notifiable Health Conditions Information System, João Pessoa, Paraíba, Brazil: a descriptive study, 2001-2019. Epidemiologia e Serviços de Saúde [Internet]. 2023 [cited 2025 Sep 19];32(2). Available from: https://www.scielo.br/j/ress/a/w5cCNtGD3Bf7kGGnM3CbMSG/?format=html&lang=en
Política Nacional de Educação Permanente em Saúde [Internet]. Ministério da Saúde. 2025 [cited 2025 Sep 19]. Available from: https://www.gov.br/saude/pt-br/composicao/sgtes/pneps
Published
Versions
- 2025-12-11 (2)
- 2025-10-29 (1)
How to Cite
Issue
Section
License
Copyright (c) 2025 Nathan Guilherme de Oliveira, Lavínia Cássia Ferreira Batista Batista, Rose Margarethe Costa, Denise da Costa Boamorte Cortela, Ricardo Souza Cavalcante, Ida Maria Foschiani Dias Baptista

This work is licensed under a Creative Commons Attribution 4.0 International License.